Revenue

EBITDA

Earnings

Price per share at the end of the period divided by the last reported earnings

Free Cash Flow

Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical trials for the treatment of Alzheimer's disease, as well as is in Phase 2 clinical trials to treat Parkinson's disease. It also develops product candidates, which are in preclinical stage, including ATH-1019 for peripheral nervous system indications; and ATH-1020 for neuropsychiatric conditions. Athira Pharma, Inc. was formerly known as M3 Biotechnology, Inc. and changed its name to Athira Pharma, Inc. in April 2019. The company was incorporated in 2011 and is headquartered in Bothell, Washington.

Athira Pharma, Inc.

The significance of a company's longevity in the market

Years since IPO

Evaluation of recent trends and improvements in the company's revenue

Revenue Growth

Assessment of recent increases in earnings per share, indicating profitability

EPS Growth

Review of the company's ability to generate free cash flow over recent periods

FCF Growth

Analysis of Return on Equity, showing how effectively the company uses equity to generate profits

Examination of debt levels using Debt/Assets and Debt/EBITDA to ensure manageable leverage

Debt

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. VANCOUVER, BRITISH COLUMBIA / ACCESS NEWSWIRE / OCTOBER 31, 2025 / ATHA ENERGY CORP. (TSXV:SASK)(FRA:X5U)(OTCQB:SASKF) ("ATHA" OR THE "COMPANY"), IS PLEASED TO ANNOUNCE THAT, FURTHER TO ITS PRESS RELEASE DATED OCTOBER 21, 2025, THE COMPANY HAS FILED ITS FINAL SHORT FORM PROSPECTUS (THE "PROSPECTUS") WITH THE SECURITIES COMMISSIONS IN BRITISH COLUMBIA, ALBERTA, SASKATCHEWAN, MANITOBA, ONTARIO AND NEW BRUNSWICK AND BEEN ISSUED A RECEIPT (THE "RECEIPT") BY THE BRITISH COLUMBIA SECURITIES COMMISSION, AS PRINCIPAL REGULATOR, IN CONNECTION WITH THE QUALIFICATION OF UP TO 18,838,752 UNITS (THE "UNITS") OF THE COMPANY ISSUABLE UPON THE EXERCISE OR DEEMED EXERCISE OF 17,126,138 SPECIAL WARRANTS ("SPECIAL WARRANTS") OF THE COMPANY ISSUED IN CONNECTION WITH ITS PREVIOUSLY ANNOUNCED PRIVATE PLACEMENT.

ATHA ANNOUNCES FILING OF A FINAL SHORT FORM PROSPECTUS

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. VANCOUVER, BC / ACCESS NEWSWIRE / OCTOBER 21, 2025 / ATHA ENERGY CORP. (TSX.V:SASK)(FRA:X5U)(OTCQB:SASKF) ("ATHA" OR THE "COMPANY"), IS PLEASED TO ANNOUNCE THAT, FURTHER TO ITS PRESS RELEASES DATED SEPTEMBER 18, 2025 AND AUGUST 11, 2025, THE COMPANY HAS FILED ITS ANNUAL INFORMATION FORM FOR THE FISCAL YEAR ENDED DECEMBER 31, 2024 (THE "AIF"), AND A PRELIMINARY SHORT FORM PROSPECTUS (THE "PROSPECTUS") WITH THE SECURITIES COMMISSIONS IN BRITISH COLUMBIA, ALBERTA, SASKATCHEWAN, MANITOBA, ONTARIO AND NEW BRUNSWICK, IN CONNECTION WITH THE PROPOSED QUALIFICATION OF UP TO 18,838,752 UNITS (THE "UNITS") OF THE COMPANY ISSUABLE UPON THE EXERCISE OR DEEMED EXERCISE OF 17,126,138 SPECIAL WARRANTS ("SPECIAL WARRANTS") OF THE COMPANY ISSUED IN CONNECTION WITH ITS PREVIOUSLY ANNOUNCED PRIVATE PLACEMENT.

ATHA ANNOUNCES FILING OF ANNUAL INFORMATION FORM AND PRELIMINARY SHORT FORM PROSPECTUS

VANCOUVER, BC / ACCESS NEWSWIRE / OCTOBER 21, 2025 / ATHA ENERGY CORP. (TSXV:SASK)(FRA:X5U)(OTCQB:SASKF) ("ATHA" OR THE "COMPANY") ANNOUNCES THAT, AS A RESULT OF A REVIEW BY THE BRITISH COLUMBIA SECURITIES COMMISSION ("BCSC"), THE COMPANY IS ISSUING THE FOLLOWING NEWS RELEASE TO CLARIFY ITS DISCLOSURE REGARDING THE ANGILAK PROJECT. THE BCSC REVIEW IDENTIFIED CERTAIN DEFICIENCIES IN THE COMPANY'S PRIOR TECHNICAL DISCLOSURE, INCLUDING THE TREATMENT OF HISTORICAL MINERAL RESOURCE ESTIMATES AND THE DISCLOSURE OF AN EXPLORATION TARGET MODEL.

ATHA CLARIFIES TECHNICAL DISCLOSURE AND FILES AN AMENDED TECHNICAL REPORT FOR ANGILAK

VANCOUVER, BRITISH COLUMBIA / ACCESS NEWSWIRE / SEPTEMBER 23, 2025 / HIGHLIGHTS MAJOR NEW DISCOVERY WITHIN THE MINERALIZED RIB CORRIDOR ("MRC"), THE RIB NORTH DISCOVERY, LOCATED ~1.4 KM ALONG STRIKE FROM THE NEAREST DRILLHOLE AT THE RIB EAST DISCOVERY (FIGURES 1 & 2); THE FIRST HOLE AT RIB NORTH, RIBN-DD-001, REPRESENTS THE MOST ROBUST MINERALIZED INTERSECTION TO DATE WITHIN THE MRC, AND ONE OF THE MOST SIGNIFICANT INTERSECTIONS WITHIN THE ANGILAK URANIUM PROJECT (FIGURE 3); DRILLHOLE RIBN-DD-001, INTERSECTED 26.3 M OF TOTAL COMPOSITE URANIUM MINERALIZATION INCLUDING 1.9 M OF HIGH-GRADE2, OVER 10 ZONES FROM 345.55 M TO 460.05 M. THE HOLE INTERSECTED 13.6 M OF CONTINUOUS MINERALIZATION (FROM 426.25 M TO 439.85 M) INCLUDING 1.7 M OF HIGH-GRADE MINERALIZATION2 WITH MAXIMUM RADIOACTIVITY OF 55,730 COUNTS PER SECOND (CPS1); MINERALIZATION WAS INITIALLY INTERSECTED DIRECTLY ABOVE THE UNCONFORMITY (LOCATED AT 356.7M), EXTENDING INTO GRAPHITIC BASEMENT ROCK.

ATHA ENERGY MAKES MAJOR NEW DISCOVERY ALONG THE RIB CORRIDOR; DRILLS BEST EXPLORATION HOLE TO DATE AT THE ANGILAK URANIUM PROJECT INTERSECTING 26.3 M OF COMPOSITE URANIUM MINERALIZATION

HIGHLIGHTS ATHA CLOSES PREVIOUSLY ANNOUNCED CAD $11.5 MILLION OVER-SUBSCRIBED BOUGHT DEAL (SEE DETAIL BELOW, "UNDERWRITTEN PRIVATE PLACEMENT"); FIRST TWO DRILL HOLES COMPLETED AT THE RIB WEST DISCOVERY SUCCESSFULLY INTERSECTED URANIUM MINERALIZATION, INCLUDING HIGH-GRADE, OVER A STRIKE LENGTH OF ~340 M (FIGURE 2); RESULTS REPRESENT THE THIRD NEW DISCOVERY OF URANIUM MINERALIZATION - BEYOND THE LAC 50 DEPOSIT TREND - DURING THE 2025 ANGILAK EXPLORATION PROGRAM, WITHIN THE ANGIKUNI BASIN ALONG THE 31 KM RIB-NINE IRON TREND (FIGURE 1); RIB EAST DISCOVERY IS CURRENTLY DEFINED BY EIGHT MINERALIZED DRILL HOLES, INTERSECTING SHALLOW URANIUM MINERALIZATION (7 MILLION ACRES) IN TWO OF THE WORLD'S MOST PROMINENT BASINS FOR URANIUM DISCOVERIES - ATHA IS WELL POSITIONED TO DRIVE VALUE. ATHA ALSO HOLDS A 10% CARRIED INTEREST IN KEY ATHABASCA BASIN EXPLORATION PROJECTS OPERATED BY NEXGEN ENERGY LTD.

ATHA ENERGY CLOSES OVER-SUBSCRIBED BOUGHT DEAL - MAKES THIRD NEW DISCOVERY OF 2025 EXPLORATION PROGRAM AT RIB WEST AND CONTINUES TO EXPAND MINERALIZATION AT RIB EAST

BOTHELL, WASH., SEPT. 11, 2025 (GLOBE NEWSWIRE) -- ATHIRA PHARMA, INC. (ATHIRA OR COMPANY) (NASDAQ: ATHA), A CLINICAL STAGE BIOPHARMACEUTICAL COMPANY FOCUSED ON DEVELOPING SMALL MOLECULES TO RESTORE NEURONAL HEALTH AND SLOW NEURODEGENERATION, TODAY ANNOUNCED THAT IT WILL EFFECT A 10-FOR-1 REVERSE STOCK SPLIT OF ATHIRA'S ISSUED AND AUTHORIZED COMMON STOCK. ATHIRA'S STOCKHOLDERS PREVIOUSLY APPROVED THE REVERSE STOCK SPLIT AND GRANTED THE BOARD OF DIRECTORS THE AUTHORITY TO DETERMINE THE EXACT SPLIT RATIO AND WHEN TO PROCEED WITH THE REVERSE STOCK SPLIT AT THE COMPANY'S ANNUAL MEETING OF STOCKHOLDERS HELD ON MAY 29, 2025.

ATHIRA PHARMA ANNOUNCES REVERSE STOCK SPLIT

ADDITIONAL UNTESTED GOLD TARGETS IN RED LAKE, ONTARIO WHITE ROCK, BC / ACCESS NEWSWIRE / SEPTEMBER 11, 2025 / ATHENA GOLD CORPORATION (CSE:ATHA)(OTCQB:AHNRF) ("ATHENA" OR THE "COMPANY") IS PLEASED TO ANNOUNCE THE IDENTIFICATION OF PROMISING GEOPHYSICAL TARGETS AT ITS LAIRD LAKE GOLD PROJECT IN ONTARIO'S PROLIFIC RED LAKE GOLD DISTRICT. RECENT ANALYSIS OF HISTORICAL GEOPHYSICS HAS HIGHLIGHTED AT LEAST SIX DISTINCT ZONES OF ELECTROMAGNETIC (EM) ANOMALISM (G1 TO G6), COMPLIMENTING THE RECENTLY ANNOUNCED GEOCHEMICAL TILL ANOMALIES (SEE PRESS RELEASE DATED SEPTEMBER 4, 2025).

ATHENA DEFINES GEOPHYSICAL TARGETS AND MOBILIZES FIELD CREW AT LAIRD LAKE

VANCOUVER, BRITISH COLUMBIA / ACCESS NEWSWIRE / SEPTEMBER 10, 2025 / ATHA ENERGY CORP. (TSX.V:SASK)(FRA:X5U)(OTCQB:SASKF) ("ATHA" OR THE "COMPANY"), AS A RESULT OF A REVIEW BY THE BRITISH COLUMBIA SECURITIES COMMISSION, THE COMPANY IS ISSUING THE FOLLOWING NEWS RELEASE TO CLARIFY CERTAIN DISCLOSURE. THE COMPANY ANNOUNCES TODAY THAT IT HAS FILED: (I) AN UPDATED TECHNICAL REPORT IN RESPECT OF ITS CMB PROPERTY LOCATED IN NEWFOUNDLAND AND LABRADOR, CANADA DATED JULY 8, 2025 AND EFFECTIVE JUNE 14, 2025 ENTITLED "NI 43-101 TECHNICAL REPORT, CENTRAL MINERAL BELT PROPERTY, NEWFOUNDLAND AND LABRADOR, CANADA" PREPARED BY STEFAN KRUSE, PH.D.

ATHA FILES UPDATED TECHNICAL REPORTS

EXCELSIOR SPRINGS FULLY FUNDED FOR 2025 DRILLING PROGRAM WHITE ROCK, BC / ACCESS NEWSWIRE / AUGUST 22, 2025 / ATHENA GOLD CORPORATION (CSE:ATHA)(OTCQB:AHNRF) ("ATHENA" OR THE "COMPANY") IS PLEASED TO ANNOUNCE THAT, FURTHER TO ITS NEWS RELEASE DATED JUNE 2, 2025, MAMMOTH MINERALS LIMITED (ASX:M79) (FORMERLY, FIRETAIL RESOURCES LIMITED) ("MAMMOTH" OR "M79") HAS EXERCISED ITS OPTION TO BE ABLE TO EARN AN 80% INTEREST IN ATHENA'S EXCELSIOR SPRINGS PROJECT IN NEVADA, USA (THE "EXCELSIOR" PROJECT), EFFECTIVE AUGUST 19, 2025 (THE "EXERCISE DATE"). IN CONSIDERATION.

ATHENA GOLD SUCCESSFULLY COMPLETES EXCELSIOR SPRINGS MONETIZATION

HIGHLIGHTS FIRST THREE DRILL HOLES COMPLETED AT RIB EAST DISCOVERY SUCCESSFULLY TARGETED STACKED GRAVITY, EM AND STRUCTURAL ANOMALIES (FIGURE 2), AND INTERSECTED URANIUM MINERALIZATION, AS PART OF THE 2025 ANGILAK EXPLORATION PROGRAM COMPRISING 10,000 M OF DIAMOND DRILLING (FIGURE 1); RESULTS REPRESENT THE SECOND NEW DISCOVERY OF URANIUM MINERALIZATION - BEYOND THE LAC 50 DEPOSIT TREND - DURING THE 2025 ANGILAK EXPLORATION PROGRAM, WITHIN THE ANGIKUNI BASIN ALONG THE 31 KM RIB-NINE IRON TREND; MINERALIZATION AT RIB EAST DISCOVERY IS CURRENTLY DEFINED BY THREE DRILL HOLES, ALL INTERSECTING SHALLOW URANIUM MINERALIZATION (10,000 CPS) OVER A CONTINUOUS 1.0 M WITH MAX RADIOACTIVITY OF 30,730 CPS 1 (FIGURE 3A, B & 6) AND A LOWER GRADE MINERALIZED FRACTURE INTERSECTED BETWEEN 372 M AND 372.6 M. RIBE-DD-003 WAS DRILLED 200 M ALONG STRIKE OF RIBE-DD-002 AND 150 M FURTHER INTO THE HANGING WALL OF AN INTERPRETED NW TRENDING FAULT ZONE.

Athira Pharma, Inc.

ATHA

Price

Financials Overview

Financial Reports

No items found.

Press Releases

Athira Pharma, Inc.

ATHA.css-1jgtvd5{-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;width:1em;height:1em;overflow:hidden;display:inline-block;text-align:center;-webkit-flex-shrink:0;-ms-flex-negative:0;flex-shrink:0;font-size:1.5rem;}

Price

Financials Overview

Financial Reports

No items found.

Press Releases

ATHA